Markowski MC, Tutrone R, Pieczonka C, Barnette KG, et al. A Phase 1b/2 Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men With Metastatic Castration-Resistant Prostate Cancer with Progression on an Androgen Receptor Targeting Agent. Clin Cancer Res 2022 Apr 13. pii: 694403. doi: 10.1158/1078-0432.CCR-22-0162.
PMID: 35416959